Chemed Corp (CHE) Stock Analysis
Recovery setup
Healthcare · Medical Care Facilities
Sell if holding. Analyst target reached at $441.62 — A.R:R is negative (-0.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Medicare and Medicaid (>95% of VITAS net patient service revenue).
Chemed operates two distinct businesses: VITAS Healthcare (one of the nation's largest hospice providers, serving terminally ill patients via Medicare/Medicaid per diem reimbursement) and Roto-Rooter (plumbing and drain cleaning services for residential and commercial customers... Read more
Sell if holding. Analyst target reached at $441.62 — A.R:R is negative (-0.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Medicare and Medicaid (>95% of VITAS net patient service revenue). Chart setup: Death cross but MACD improving, RSI 73. Score 4.7/10, moderate confidence.
Passes 6/9 gates (positive momentum, clean insider activity, no SEC red flags, earnings proximity 70d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and news legal. Suitability: moderate.
Recent Developments — Chemed Corp
Latest news
- Chemed (CHE) Q1 Earnings: What To Expect - Yahoo Finance — Yahoo Finance neutral
- Chemed (CHE) Q1 Earnings: What To Expect - TradingView — TradingView neutral
- Chemed (CHE) Q1 Earnings: What To Expect - FinancialContent — FinancialContent neutral
- Chemed Corporation (NYSE:CHE) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat — MarketBeat neutral
- Chemed’s (NYSE:CHE) Q1 CY2026 Sales Top Estimates, Stock Jumps 10.2% - StockStory — StockStory positive
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerMedicare and Medicaid (>95% of VITAS net patient service revenue)10-K Item 1A: 'In excess of 95% of VITAS’ net patient service revenue consists of payments from the Medicare and Medicaid programs'
- MEDIUMGeographicFlorida (significant portion of VITAS operations)10-K Item 1: 'A significant portion of our VITAS business is operated in the state of Florida'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
3 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $441.62 — A.R:R is negative (-0.9) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Medicare and Medicaid (>95% of VITAS net patient service revenue). Chart setup: Death cross but MACD improving, RSI 73. Prior stop was $419.36. Score 4.7/10, moderate confidence.
Take-profit target: $444.54 (+0.7% upside). Prior stop was $419.36. Stop-loss: $419.36.
Concentration risk — Customer: Medicare and Medicaid (>95% of VITAS net patient service revenue); Analyst target reached - limited upside remaining; Consecutive earnings misses (3).
Chemed Corp trades at a P/E of 24.1 (forward 16.4). TrendMatrix value score: 5.3/10. Verdict: Sell.
8 analysts cover CHE with a consensus score of 3.8/5. Average price target: $447.
What does Chemed Corp do?Chemed operates two distinct businesses: VITAS Healthcare (one of the nation's largest hospice providers, serving...
Chemed operates two distinct businesses: VITAS Healthcare (one of the nation's largest hospice providers, serving terminally ill patients via Medicare/Medicaid per diem reimbursement) and Roto-Rooter (plumbing and drain cleaning services for residential and commercial customers nationwide). Over 95% of VITAS revenue comes from Medicare and Medicaid.